NCT07438080 Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV. A Randomized Controlled Crossover Study
| NCT ID | NCT07438080 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de la Réunion |
| Condition | HPV |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-04-09 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-04-09 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Comunity health actions are set up in populations of women aged 30 to 65 in vulnerable situations living in the outlying areas of Reunion Island. The idea is to evaluate those action on health
Eligibility Criteria
Inclusion Criteria: * Aged 30 to 65, * In a vulnerable situation (beneficiary of a state or departmental social service, or referred by a charity), * Resident in one of the two municipalities targeted by the study, * Supported by the social services of one of the two municipalities targeted by the study, * Having agreed to participate in sexual health awareness meetings organized on site Exclusion Criteria: * Refusing to participate in the study * Having had a hysterectomy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07438080 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 65 Years, studying HPV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07438080 currently recruiting?
Yes, NCT07438080 is actively recruiting participants. Contact the research team at direction@chor.re for enrollment information.
Where is the NCT07438080 trial being conducted?
This trial is being conducted at Saint-Paul, France, Saint-Pierre, France.
Who is sponsoring the NCT07438080 clinical trial?
NCT07438080 is sponsored by Centre Hospitalier Universitaire de la Réunion. The trial plans to enroll 300 participants.